Suppr超能文献

鉴定人尿中β1-3 半乳糖基葡萄糖核心游离聚糖。

Identification of β1-3 galactosylglucose-core free-glycans in human urine.

机构信息

Department of Molecular Biology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.

Department of Medical Checkup, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka, 541-8567, Japan.

出版信息

Anal Biochem. 2022 Mar 15;641:114427. doi: 10.1016/j.ab.2021.114427. Epub 2021 Oct 21.

Abstract

We previously reported the precise structure of acidic free-glycans in human urine. In the present study, structural analysis of neutral free-glycans in urine was performed in fine detail. Urine samples were collected from 21 healthy volunteers and free-glycans extracted from the creatinine-adjusted urine and then fluorescently labeled with 2-aminopyridine. Neutral glycan profiling was achieved by a combination of high-performance liquid chromatography, mass spectrometry, enzymatic digestion, and periodate cleavage. A total of 79 glycans were identified. Because the ABO-blood group antigen containing urinary neutral glycans are major components, profiling patterns were similar between individuals of the same ABO-group. The neutral glycans were composed of lactose-core (Galβ1-4Glc) glycans, type-II N-acetyllactosamine-core (GlcNAcβ1-4Glc) glycans, hexose oligomers, N-glycans and to our surprise β1-3 galactosylglucose-core (Galβ1-3Glc) glycans. Although glycans with a β1-3 galactosylglucose-core were identified as major components in urine, comprising structurally simple isomers of a lactose-core, the core structure has not previously been reported. The major β1-3 galactosylglucose-core glycans were Fucα1-2Galβ1-3(Fucα1-4)Glc, GalNAcα1-3(Fucα1-2)Galβ1-3(Fucα1-4)Glc and Galα1-3(Fucα1-2)Galβ1-3(Fucα1-4)Glc, corresponding to H-, A-, and B-blood group antigens, respectively. Three lactosamine extended β1-3 galactosylglucose-core glycans were also detected as minor components. Elucidating the biosynthesis of β1-3 galactosylglucose will be crucial for understanding the in vivo function of these glycans.

摘要

我们之前报道了人尿液中酸性游离聚糖的精确结构。在本研究中,我们详细分析了尿液中中性游离聚糖的结构。收集了 21 名健康志愿者的尿液样本,从肌酐调整后的尿液中提取游离聚糖,并用 2-氨基吡啶进行荧光标记。通过高效液相色谱、质谱、酶消化和过碘酸盐裂解的组合,实现了中性聚糖的分析。共鉴定出 79 种聚糖。由于 ABO 血型抗原含有尿液中的中性聚糖,因此同一 ABO 组个体的图谱模式相似。中性聚糖由乳糖核心(Galβ1-4Glc)聚糖、Ⅱ型 N-乙酰乳糖胺核心(GlcNAcβ1-4Glc)聚糖、六糖寡聚物、N-聚糖和令我们惊讶的β1-3 半乳糖基葡萄糖核心(Galβ1-3Glc)聚糖组成。尽管含有β1-3 半乳糖基葡萄糖核心的聚糖被鉴定为尿液中的主要成分,构成乳糖核心的结构简单异构体,但核心结构以前没有报道过。主要的β1-3 半乳糖基葡萄糖核心聚糖是 Fucα1-2Galβ1-3(Fucα1-4)Glc、GalNAcα1-3(Fucα1-2)Galβ1-3(Fucα1-4)Glc 和 Galα1-3(Fucα1-2)Galβ1-3(Fucα1-4)Glc,分别对应于 H-、A-和 B-血型抗原。还检测到三种乳糖胺延伸的β1-3 半乳糖基葡萄糖核心聚糖作为次要成分。阐明β1-3 半乳糖基葡萄糖的生物合成对于理解这些聚糖的体内功能至关重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验